Secukinumab survival and long-term efficacy in patients with plaque psoriasis: real-life data from a tertiary hospital in Greece

被引：11
作者：
Sotiriou, E. [1 ]
Tsentemeidou, A. [1 ]
Vakirlis, E. [1 ]
Sideris, N. [1 ]
Ioannides, D. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Sch Med, Dermatol Dept 1, Thessaloniki, Greece
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 02期
关键词：
DRUG SURVIVAL; MULTICENTER; MODERATE; SAFETY;
D O I：
10.1111/jdv.15231
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E82 / E84
页数：3
相关论文
共 10 条
[1]   Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis [J].
Egeberg, A. ;
Ottosen, M. B. ;
Gniadecki, R. ;
Broesby-Olsen, S. ;
Dam, T. N. ;
Bryld, L. E. ;
Rasmussen, M. K. ;
Skov, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) :509-519
[2]   Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis [J].
Frieder, Jillian ;
Kivelevitch, Dario ;
Menter, Alan .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (01) :5-21
[3]   Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study [J].
Georgakopoulos, Jorge R. ;
Ighani, Arvin ;
Phung, Michelle ;
Yeung, Jensen .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) :1019-1020
[4]   Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks: Update and commentary [J].
Huang, Yuan Yu Michael ;
Hsu, Sylvia .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06)
[5]   Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials [J].
Langley, Richard G. ;
Elewski, Boni E. ;
Lebwohl, Mark ;
Reich, Kristian ;
Griffiths, Christopher E. M. ;
Papp, Kim ;
Puig, Lluis ;
Nakagawa, Hidemi ;
Spelman, Lynda ;
Sigurgeirsson, Bardur ;
Rivas, Enrique ;
Tsai, Tsen-Fang ;
Wasel, Norman ;
Tyring, Stephen ;
Salko, Thomas ;
Hampele, Isabelle ;
Notter, Marianne ;
Karpov, Alexander ;
Helou, Silvia ;
Papavassilis, Charis .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) :326-338
[6]   Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review [J].
Lee, Erica B. ;
Amin, Mina ;
Man, Jeremy ;
Egeberg, Alexander ;
Wu, Jashin J. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (07) :671-675
[7]   Long-term clinical efficacy and safety of secukinumab for Japanese patients with psoriasis: A single-center experience [J].
Momose, Mami ;
Asahina, Akihiko ;
Umezawa, Yoshinori ;
Nakagawa, Hidemi .
JOURNAL OF DERMATOLOGY, 2018, 45 (03) :318-321
[8]   Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE) [J].
Mrowietz, Ulrich ;
Leonardi, Craig L. ;
Girolomoni, Giampiero ;
Toth, Darryl ;
Morita, Akimichi ;
Balki, Shyamal A. ;
Szepietowski, Jacek C. ;
Regnault, Pascaline ;
Thurston, Helen ;
Papavassilis, Charis .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) :27-U109
[9]   Treatment optimization with secukinumab 150 mg for moderate-to-severe psoriasis in clinical practice: a single-center open-label 52-week study [J].
Munoz-Santos, Carlos ;
Sola-Ortigosa, Joaquin ;
Guilabert, Antonio .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (05) :615-617
[10]   Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study [J].
van den Reek, Juul M. P. A. ;
van Vugt, Lieke J. ;
van Doorn, Martijn B. A. ;
van der Kraaij, Gayle E. ;
de Kort, Wim J. A. ;
Lucker, Georges P. H. ;
Horvath, Barbara ;
Njoo, M. David ;
Bovenschen, H. Jorn ;
Ossenkoppele, Paul M. ;
De Bruin-Weller, Marjolein S. ;
de Groot, Marjan ;
Mommers, Roland ;
Prevoo, Ruud L. M. A. ;
van de Kerkhof, Peter C. M. ;
Spuls, Phyllis I. ;
Kievit, Wietske ;
de Jong, Elke M. G. J. .
ACTA DERMATO-VENEREOLOGICA, 2018, 98 (07) :648-654
1